SEC Form D · filed November 9, 2021
Shoreline Biosciences, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Christopher S. Fuglesang · San Diego, CADirectorMarios G. Fotiadis · San Diego, CADirectorSteven G. Holtzman · San Diego, CADirectorDan S. Kaufman · San Diego, CADirectorKimberly S. Manhard · San Diego, CADirectorKleanthis G. Xanthopoulos · SAN DIEGO, CAExec · DirectorJohn W. Lobdell · Daytona Beach, FLDirectorTrevor W. Perrott · Daytona Beach, FLDirectorThomas Bailey · HOBE SOUND, FLDirectorDavid W. Scalzo · Daytona Beach, FLDirectorVanessa S. Jacoby · San Diego, CAExecWilliam S. Sandborn · San Diego, CAExecScott S. Forrest · San Diego, CAExecFan S. Yu · San Diego, CADirectorJeffrey L. Ives · Newton Centre, MADirectorJustin L. Burns · Newton Centre, MADirectorMartin Jefson · Newton Centre, MADirectorAlexandra A. Clegg · Warwick, RIDirectorVanessa S. Jacoby · San Diego, CAExecWilliam S. Sandborn · San Diego, CAExecKimberly S. Manhard · San Diego, CADirectorScott S. Forrest · San Diego, CAExecFan S. Yu · San Diego, CADirectorKleanthis G. Xanthopoulos · San Diego, CAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗